img

Pharmacovigilance (PV) and Drug Safety Software


Published on: 2024-01-04 | No of Pages : 159 | Industry : Service & Software

Publisher : MRA | Format : PDF&Excel

Pharmacovigilance (PV) and Drug Safety Software

The research team projects that the Pharmacovigilance (PV) and Drug Safety Software market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2022 to 2027.



By Market Players

AB Cube

Sparta Systems, Inc.

Oracle Corporation

EXTEDO GmbH

Ennov Solutions, Inc.

ArisGlobal

United BioSource Corporation

Online Business Applications, Inc.



By Type

Cloud based

On-premises



By Application

Pharma and Biotech

Contract Research Organizations (CROs)

Business Process Outsourcing (BPO) Firms

Other







Points Covered in The Report

The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.

The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.

The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.

Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.

The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.



Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.



The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Pharmacovigilance (PV) and Drug Safety Software 2016-2021, and development forecast 2022-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.



Key Indicators Analysed

Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2021 & Sales by Product Types.

Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2022-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.

Market Analysis by Product TypeThe report covers majority Product Types in the Pharmacovigilance (PV) and Drug Safety Software Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).

Markat Analysis by Application TypeBased on the Pharmacovigilance (PV) and Drug Safety Software Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.

Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.

Opportunities and DriversIdentifying the Growing Demands and New Technology

Porters Five Force AnalysisThe report will provide with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.



COVID-19 Impact

Report covers Impact of Coronavirus COVID-19Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Pharmacovigilance (PV) and Drug Safety Software market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by Pharmacovigilance (PV) and Drug Safety Software Revenue

1.4 Market Analysis by Type

1.4.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Size Growth Rate by Type: 2021 VS 2027

1.4.2 Cloud based

1.4.3 On-premises

1.5 Market by Application

1.5.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Share by Application: 2022-2027

1.5.2 Pharma and Biotech

1.5.3 Contract Research Organizations (CROs)

1.5.4 Business Process Outsourcing (BPO) Firms

1.5.5 Other

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Perspective (2022-2027)

2.2 Pharmacovigilance (PV) and Drug Safety Software Growth Trends by Regions

2.2.1 Pharmacovigilance (PV) and Drug Safety Software Market Size by Regions: 2016 VS 2022 VS 2027

2.2.2 Pharmacovigilance (PV) and Drug Safety Software Historic Market Size by Regions (2016-2021)

2.2.3 Pharmacovigilance (PV) and Drug Safety Software Forecasted Market Size by Regions (2022-2027)

2.3 Industry Trends and Growth Strategy

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Challenges

2.3.4 Porter’s Five Forces Analysis

2.3.5 Pharmacovigilance (PV) and Drug Safety Software Market Growth Strategy

3 Market Competition by Manufacturers

3.1 Global Pharmacovigilance (PV) and Drug Safety Software Production Capacity Market Share by Manufacturers (2016-2021)

3.2 Global Pharmacovigilance (PV) and Drug Safety Software Revenue Market Share by Manufacturers (2016-2021)

3.3 Global Pharmacovigilance (PV) and Drug Safety Software Average Price by Manufacturers (2016-2021)

3.4 Manufacturers Pharmacovigilance (PV) and Drug Safety Software Production Sites, Area Served, Product Type

4 Pharmacovigilance (PV) and Drug Safety Software Sales Market by Type (2016-2027)

4.1 Global Pharmacovigilance (PV) and Drug Safety Software Historic Market Size by Type (2016-2021)

4.2 Global Pharmacovigilance (PV) and Drug Safety Software Forecasted Market Size by Type (2022-2027)

5 Pharmacovigilance (PV) and Drug Safety Software Consumption Market by Application(2016-2027)

5.1 Global Pharmacovigilance (PV) and Drug Safety Software Historic Market Size by Application (2016-2021)

5.2 Global Pharmacovigilance (PV) and Drug Safety Software Forecasted Market Size by Application (2022-2027)

6 North America

6.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Size (2016-2027)

6.2 Pharmacovigilance (PV) and Drug Safety Software Key Players in North America (2016-2021)

6.3 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021)

6.4 North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021)

7 East Asia

7.1 East Asia Pharmacovigilance (PV) and Drug Safety Software Market Size (2016-2027)

7.2 Pharmacovigilance (PV) and Drug Safety Software Key Players in East Asia (2016-2021)

7.3 East Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021)

7.4 East Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021)

8 Europe

8.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size (2016-2027)

8.2 Pharmacovigilance (PV) and Drug Safety Software Key Players in Europe (2016-2021)

8.3 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021)

8.4 Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021)

9 South Asia

9.1 South Asia Pharmacovigilance (PV) and Drug Safety Software Market Size (2016-2027)

9.2 Pharmacovigilance (PV) and Drug Safety Software Key Players in South Asia (2016-2021)

9.3 South Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021)

9.4 South Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021)

10 Southeast Asia

10.1 Southeast Asia Pharmacovigilance (PV) and Drug Safety Software Market Size (2016-2027)

10.2 Pharmacovigilance (PV) and Drug Safety Software Key Players in Southeast Asia (2016-2021)

10.3 Southeast Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021)

10.4 Southeast Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021)

11 Middle East

11.1 Middle East Pharmacovigilance (PV) and Drug Safety Software Market Size (2016-2027)

11.2 Pharmacovigilance (PV) and Drug Safety Software Key Players in Middle East (2016-2021)

11.3 Middle East Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021)

11.4 Middle East Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021)

12 Africa

12.1 Africa Pharmacovigilance (PV) and Drug Safety Software Market Size (2016-2027)

12.2 Pharmacovigilance (PV) and Drug Safety Software Key Players in Africa (2016-2021)

12.3 Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021)

12.4 Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021)

13 Oceania

13.1 Oceania Pharmacovigilance (PV) and Drug Safety Software Market Size (2016-2027)

13.2 Pharmacovigilance (PV) and Drug Safety Software Key Players in Oceania (2016-2021)

13.3 Oceania Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021)

13.4 Oceania Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021)

14 South America

14.1 South America Pharmacovigilance (PV) and Drug Safety Software Market Size (2016-2027)

14.2 Pharmacovigilance (PV) and Drug Safety Software Key Players in South America (2016-2021)

14.3 South America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021)

14.4 South America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021)

15 Rest of the World

15.1 Rest of the World Pharmacovigilance (PV) and Drug Safety Software Market Size (2016-2027)

15.2 Pharmacovigilance (PV) and Drug Safety Software Key Players in Rest of the World (2016-2021)

15.3 Rest of the World Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021)

15.4 Rest of the World Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021)

16 Company Profiles and Key Figures in Pharmacovigilance (PV) and Drug Safety Software Business

16.1 AB Cube

16.1.1 AB Cube Company Profile

16.1.2 AB Cube Pharmacovigilance (PV) and Drug Safety Software Product Specification

16.1.3 AB Cube Pharmacovigilance (PV) and Drug Safety Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.2 Sparta Systems, Inc.

16.2.1 Sparta Systems, Inc. Company Profile

16.2.2 Sparta Systems, Inc. Pharmacovigilance (PV) and Drug Safety Software Product Specification

16.2.3 Sparta Systems, Inc. Pharmacovigilance (PV) and Drug Safety Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.3 Oracle Corporation

16.3.1 Oracle Corporation Company Profile

16.3.2 Oracle Corporation Pharmacovigilance (PV) and Drug Safety Software Product Specification

16.3.3 Oracle Corporation Pharmacovigilance (PV) and Drug Safety Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.4 EXTEDO GmbH

16.4.1 EXTEDO GmbH Company Profile

16.4.2 EXTEDO GmbH Pharmacovigilance (PV) and Drug Safety Software Product Specification

16.4.3 EXTEDO GmbH Pharmacovigilance (PV) and Drug Safety Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.5 Ennov Solutions, Inc.

16.5.1 Ennov Solutions, Inc. Company Profile

16.5.2 Ennov Solutions, Inc. Pharmacovigilance (PV) and Drug Safety Software Product Specification

16.5.3 Ennov Solutions, Inc. Pharmacovigilance (PV) and Drug Safety Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.6 ArisGlobal

16.6.1 ArisGlobal Company Profile

16.6.2 ArisGlobal Pharmacovigilance (PV) and Drug Safety Software Product Specification

16.6.3 ArisGlobal Pharmacovigilance (PV) and Drug Safety Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.7 United BioSource Corporation

16.7.1 United BioSource Corporation Company Profile

16.7.2 United BioSource Corporation Pharmacovigilance (PV) and Drug Safety Software Product Specification

16.7.3 United BioSource Corporation Pharmacovigilance (PV) and Drug Safety Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.8 Online Business Applications, Inc.

16.8.1 Online Business Applications, Inc. Company Profile

16.8.2 Online Business Applications, Inc. Pharmacovigilance (PV) and Drug Safety Software Product Specification

16.8.3 Online Business Applications, Inc. Pharmacovigilance (PV) and Drug Safety Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)

17 Analyst's Viewpoints/Conclusions

18 Appendix

18.1 Research Methodology

18.1.1 Methodology/Research Approach

18.1.2 Data Source

18.2 Disclaimer



List of Figure

Table 1. Key Players Covered: Ranking by Pharmacovigilance (PV) and Drug Safety Software Revenue (US$ Million) 2016-2021

Table 2. Global Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (US$ Million): 2022-2027

Table 3. Global Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (US$ Million): 2022-2027

Table 4. Global Pharmacovigilance (PV) and Drug Safety Software Market Size by Regions (US$ Million): 2022-2027

Table 5. Global Pharmacovigilance (PV) and Drug Safety Software Market Size by Regions (2016-2021) (US$ Million)

Table 6. Global Pharmacovigilance (PV) and Drug Safety Software Market Share by Regions (2016-2021)

Table 7. Global Pharmacovigilance (PV) and Drug Safety Software Forecasted Market Size by Regions (2022-2027) (US$ Million)

Table 8. Global Pharmacovigilance (PV) and Drug Safety Software Market Share by Regions (2022-2027)

Table 9. Market Top Trends

Table 10. Key Drivers: Impact Analysis

Table 11. Key Challenges

Table 12. Pharmacovigilance (PV) and Drug Safety Software Market Growth Strategy

Table 13. Global Pharmacovigilance (PV) and Drug Safety Software Production Capacity by Manufacturers

Table 14. Global Pharmacovigilance (PV) and Drug Safety Software Production by Manufacturers (2016-2021)

Table 15. Global Pharmacovigilance (PV) and Drug Safety Software Production Market Share by Manufacturers (2016-2021)

Table 16. Global Pharmacovigilance (PV) and Drug Safety Software Revenue by Manufacturers (2016-2021)

Table 17. Global Pharmacovigilance (PV) and Drug Safety Software Revenue Share by Manufacturers (2016-2021)

Table 18. Global Market Pharmacovigilance (PV) and Drug Safety Software Average Price of Key Manufacturers (2016-2021)

Table 19. Manufacturers Pharmacovigilance (PV) and Drug Safety Software Production Sites and Area Served

Table 20. Manufacturers Pharmacovigilance (PV) and Drug Safety Software Product Type

Table 21. Global Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) (US$ Million)

Table 22. Global Pharmacovigilance (PV) and Drug Safety Software Revenue Market Share by Type (2016-2021)

Table 23. Global Pharmacovigilance (PV) and Drug Safety Software Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 24. Global Pharmacovigilance (PV) and Drug Safety Software Revenue Market Share by Type (2022-2027)

Table 25. Global Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) (US$ Million)

Table 26. Global Pharmacovigilance (PV) and Drug Safety Software Revenue Market Share by Application (2016-2021)

Table 27. Global Pharmacovigilance (PV) and Drug Safety Software Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 28. Global Pharmacovigilance (PV) and Drug Safety Software Revenue Market Share by Application (2022-2027)

Table 29. North America Key Players Pharmacovigilance (PV) and Drug Safety Software Revenue (2016-2021) (US$ Million)

Table 30. North America Key Players Pharmacovigilance (PV) and Drug Safety Software Market Share (2016-2021)

Table 31. North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) (US$ Million)

Table 32. North America Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2016-2021)

Table 33. North America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) (US$ Million)

Table 34. North America Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2016-2021)

Table 35. East Asia Key Players Pharmacovigilance (PV) and Drug Safety Software Revenue (2016-2021) (US$ Million)

Table 36. East Asia Key Players Pharmacovigilance (PV) and Drug Safety Software Market Share (2016-2021)

Table 37. East Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) (US$ Million)

Table 38. East Asia Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2016-2021)

Table 39. East Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) (US$ Million)

Table 40. East Asia Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2016-2021)

Table 41. Europe Key Players Pharmacovigilance (PV) and Drug Safety Software Revenue (2016-2021) (US$ Million)

Table 42. Europe Key Players Pharmacovigilance (PV) and Drug Safety Software Market Share (2016-2021)

Table 43. Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) (US$ Million)

Table 44. Europe Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2016-2021)

Table 45. Europe Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) (US$ Million)

Table 46. Europe Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2016-2021)

Table 47. South Asia Key Players Pharmacovigilance (PV) and Drug Safety Software Revenue (2016-2021) (US$ Million)

Table 48. South Asia Key Players Pharmacovigilance (PV) and Drug Safety Software Market Share (2016-2021)

Table 49. South Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) (US$ Million)

Table 50. South Asia Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2016-2021)

Table 51. South Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) (US$ Million)

Table 52. South Asia Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2016-2021)

Table 53. Southeast Asia Key Players Pharmacovigilance (PV) and Drug Safety Software Revenue (2016-2021) (US$ Million)

Table 54. Southeast Asia Key Players Pharmacovigilance (PV) and Drug Safety Software Market Share (2016-2021)

Table 55. Southeast Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) (US$ Million)

Table 56. Southeast Asia Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2016-2021)

Table 57. Southeast Asia Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) (US$ Million)

Table 58. Southeast Asia Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2016-2021)

Table 59. Middle East Key Players Pharmacovigilance (PV) and Drug Safety Software Revenue (2016-2021) (US$ Million)

Table 60. Middle East Key Players Pharmacovigilance (PV) and Drug Safety Software Market Share (2016-2021)

Table 61. Middle East Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) (US$ Million)

Table 62. Middle East Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2016-2021)

Table 63. Middle East Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) (US$ Million)

Table 64. Middle East Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2016-2021)

Table 65. Africa Key Players Pharmacovigilance (PV) and Drug Safety Software Revenue (2016-2021) (US$ Million)

Table 66. Africa Key Players Pharmacovigilance (PV) and Drug Safety Software Market Share (2016-2021)

Table 67. Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) (US$ Million)

Table 68. Africa Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2016-2021)

Table 69. Africa Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) (US$ Million)

Table 70. Africa Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2016-2021)

Table 71. Oceania Key Players Pharmacovigilance (PV) and Drug Safety Software Revenue (2016-2021) (US$ Million)

Table 72. Oceania Key Players Pharmacovigilance (PV) and Drug Safety Software Market Share (2016-2021)

Table 73. Oceania Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) (US$ Million)

Table 74. Oceania Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2016-2021)

Table 75. Oceania Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) (US$ Million)

Table 76. Oceania Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2016-2021)

Table 77. South America Key Players Pharmacovigilance (PV) and Drug Safety Software Revenue (2016-2021) (US$ Million)

Table 78. South America Key Players Pharmacovigilance (PV) and Drug Safety Software Market Share (2016-2021)

Table 79. South America Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) (US$ Million)

Table 80. South America Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2016-2021)

Table 81. South America Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) (US$ Million)

Table 82. South America Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2016-2021)

Table 83. Rest of the World Key Players Pharmacovigilance (PV) and Drug Safety Software Revenue (2016-2021) (US$ Million)

Table 84. Rest of the World Key Players Pharmacovigilance (PV) and Drug Safety Software Market Share (2016-2021)

Table 85. Rest of the World Pharmacovigilance (PV) and Drug Safety Software Market Size by Type (2016-2021) (US$ Million)

Table 86. Rest of the World Pharmacovigilance (PV) and Drug Safety Software Market Share by Type (2016-2021)

Table 87. Rest of the World Pharmacovigilance (PV) and Drug Safety Software Market Size by Application (2016-2021) (US$ Million)

Table 88. Rest of the World Pharmacovigilance (PV) and Drug Safety Software Market Share by Application (2016-2021)

Table 89. AB Cube Pharmacovigilance (PV) and Drug Safety Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 90. Sparta Systems, Inc. Pharmacovigilance (PV) and Drug Safety Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 91. Oracle Corporation Pharmacovigilance (PV) and Drug Safety Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 92. Table EXTEDO GmbH Pharmacovigilance (PV) and Drug Safety Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 93. Ennov Solutions, Inc. Pharmacovigilance (PV) and Drug Safety Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 94. ArisGlobal Pharmacovigilance (PV) and Drug Safety Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 95. United BioSource Corporation Pharmacovigilance (PV) and Drug Safety Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 96. Online Business Applications, Inc. Pharmacovigilance (PV) and Drug Safety Software Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources





Figure 1. Global Pharmacovigilance (PV) and Drug Safety Software Market Share by Type: 2021 VS 2027

Figure 2. Cloud based Features

Figure 3. On-premises Features

Figure 11. Global Pharmacovigilance (PV) and Drug Safety Software Market Share by Application: 2021 VS 2027

Figure 12. Pharma and Biotech Case Studies

Figure 13. Contract Research Organizations (CROs) Case Studies

Figure 14. Business Process Outsourcing (BPO) Firms Case Studies

Figure 15. Other Case Studies

Figure 21. Pharmacovigilance (PV) and Drug Safety Software Report Years Considered

Figure 22. Global Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth 2022-2027 (US$ Million)

Figure 23. Global Pharmacovigilance (PV) and Drug Safety Software Market Share by Regions: 2022 VS 2027

Figure 24. Porter's Five Forces Analysis

Figure 25. North America Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) (US$ Million)

Figure 26. East Asia Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) (US$ Million)

Figure 27. Europe Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) (US$ Million)

Figure 28. South Asia Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) (US$ Million)

Figure 29. Southeast Asia Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) (US$ Million)

Figure 30. Middle East Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) (US$ Million)

Figure 31. Africa Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) (US$ Million)

Figure 32. Oceania Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) (US$ Million)

Figure 33. South America Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) (US$ Million)

Figure 34. Rest of the World Pharmacovigilance (PV) and Drug Safety Software Market Size YoY Growth (2016-2027) (US$ Million)

Figure 35. AB Cube Pharmacovigilance (PV) and Drug Safety Software Product Specification

Figure 36. Sparta Systems, Inc. Pharmacovigilance (PV) and Drug Safety Software Product Specification

Figure 37. Oracle Corporation Pharmacovigilance (PV) and Drug Safety Software Product Specification

Figure 38. EXTEDO GmbH Pharmacovigilance (PV) and Drug Safety Software Product Specification

Figure 39. Ennov Solutions, Inc. Pharmacovigilance (PV) and Drug Safety Software Product Specification

Figure 40. ArisGlobal Pharmacovigilance (PV) and Drug Safety Software Product Specification

Figure 41. United BioSource Corporation Pharmacovigilance (PV) and Drug Safety Software Product Specification

Figure 42. Online Business Applications, Inc. Pharmacovigilance (PV) and Drug Safety Software Product Specification

Figure 85. Key Executives Interviewed